[{"id":5889,"regimens":[{"id":11001,"duration":{"id":5059,"approximate_duration":"14 days","dates_unknown":true},"drug":{"id":11228,"name":"Tenofovir Disoproxil Fumarate","url":"cure-api2.ncats.io/v1/drugs/11228","rxNorm_id":null,"notes":null},"use_drug":[{"id":7304,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11001},{"id":7305,"answer":"In a novel combination with another drug","answer_other":"","regimen":11001}],"created":"2020-09-13T22:26:47.411837Z","updated":"2020-10-06T22:14:52.041399Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":5889},{"id":11002,"duration":{"id":5060,"approximate_duration":"14 days","dates_unknown":true},"drug":{"id":7601,"name":"Emtricitabine","url":"cure-api2.ncats.io/v1/drugs/7601","rxNorm_id":null,"notes":null},"use_drug":[{"id":7306,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11002},{"id":7307,"answer":"In a novel combination with another drug","answer_other":"","regimen":11002}],"created":"2020-09-13T22:26:47.419432Z","updated":"2020-10-06T22:14:52.047802Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":5889},{"id":11003,"duration":{"id":5061,"approximate_duration":"14 days","dates_unknown":true},"drug":{"id":8783,"name":"Lopinavir-Ritonavir","url":"cure-api2.ncats.io/v1/drugs/8783","rxNorm_id":null,"notes":null},"use_drug":[{"id":7308,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11003},{"id":7309,"answer":"In a novel combination with another drug","answer_other":"","regimen":11003}],"created":"2020-09-13T22:26:47.425423Z","updated":"2020-10-06T22:14:52.053618Z","dose":"400/100 mg","frequency":"BD","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":5889},{"id":11004,"duration":{"id":5062,"approximate_duration":"5 days","dates_unknown":true},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":7310,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11004},{"id":7311,"answer":"In a novel combination with another drug","answer_other":"","regimen":11004}],"created":"2020-09-13T22:26:47.431887Z","updated":"2020-10-06T22:14:52.059388Z","dose":"400 mg twice a day with a loading dose on the first day and then 200 mg twice a day for 4 days","frequency":"BD","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":5889},{"id":11005,"duration":{"id":5063,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7066,"name":"Corticosteroids","url":"cure-api2.ncats.io/v1/drugs/7066","rxNorm_id":null,"notes":null},"use_drug":[{"id":7312,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11005},{"id":7313,"answer":"In a novel combination with another drug","answer_other":"","regimen":11005}],"created":"2020-09-13T22:26:47.438508Z","updated":"2020-10-06T22:14:52.065071Z","dose":"","frequency":"","route":"inhaled","severity":"Inpatient","severity_detail":"","comments":null,"report":5889}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":7704,"answer":"Clinical assessment","answer_other":"","report":5889}],"how_diagnosis":[{"id":13102,"answer":"Clinical assessment","answer_other":"","report":5889},{"id":13103,"answer":"Imaging","answer_other":"","report":5889},{"id":13104,"answer":"PCR","answer_other":"","report":5889}],"author_username":"Reema Charles","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Medical Doctor","author_affiliation":"None","author_country":"","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":3820,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":5889}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"},{"id":550,"name":"Respiratory Tract Infections"}],"races":[{"id":192,"answer":"White","answer_other":""}],"created":"2020-09-13T22:24:35.370712Z","updated":"2020-10-06T22:14:52.033387Z","title":"COVID-19 in patients with HIV: clinical case series. Case 4","status":"Approved","anonymous":false,"published":true,"pubmed_id":32304642,"doi":"10.1016/S2352-3018(20)30111-9","article_url":"https://pubmed.ncbi.nlm.nih.gov/32304642/","pub_year":2020,"published_authors":"Blanco JL\r\nAmbrosioni J\r\nGarcia F\r\nMartínez E\r\nSoriano A\r\nMallolas J\r\nMiro JM\r\nCOVID-19 in HIV Investigators.","article_author_email":"Author email could not be found.","journal":"The lancet. HIV","abstract":"On March 9, 2020, 2 weeks into the COVID-19 outbreak in Spain, 543 consecutive patients with SARS-CoV-2 infection had been admitted to hospital at Hospital Clínic Barcelona, Barcelona, Spain. We admitted 62 (12%) into intensive care units and we discharged 208 (38%) with supervised outpatient care. Of all patients, five (0·92%; 95% 0·39–2·14) were HIV positive, of whom three were male and two were transgender, and four identified as men who have sex with men (MSM). Two patients had comorbid conditions.","article_type":"Original","study_type":"Case Report","number_of_patients":5,"article_patient_number":"4","full_text_available":true,"outcome":"Patient was cured/recovered","surgery":"No","age":"31-40 years","sex":"Male","ethnicity":"Hispanic/Latino","country_contracted":"Spain","country_treated":"Spain","began_treatment_year":"2020","hiv":true,"asthma":true,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"ART - Abacavir, lamivudine; and dolutegravir","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Respiratory tract infection","severity":null,"prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"","follow_up_period":null,"relapse":"Unknown","reminder":false,"when_reminder":"1 week","additional_info":"MSM, sexual worker participant in ChemSex session 6 days before. \r\n\r\nART admission - Tenofovir disoproxil fumarate, and emtricitabine plus lopinavir-boosted ritonavir (for 14 days).\r\n\r\nRight basal interstitial infiltrate\r\n\r\nLength of hospital stay (days) - 4\r\n\r\nConcomitant antibacterials (Azithromycin and Cefixime) for pneumonia","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[7066,7601,8342,8783,11228]},{"id":5890,"regimens":[{"id":11006,"duration":{"id":5064,"approximate_duration":"on-going","dates_unknown":true},"drug":{"id":11227,"name":"Tenofovir Alafenamide","url":"cure-api2.ncats.io/v1/drugs/11227","rxNorm_id":null,"notes":null},"use_drug":[{"id":7314,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11006},{"id":7315,"answer":"In a novel combination with another drug","answer_other":"","regimen":11006}],"created":"2020-09-13T22:57:43.459174Z","updated":"2020-09-13T23:13:38.887426Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":5890},{"id":11007,"duration":{"id":5065,"approximate_duration":"on-going","dates_unknown":true},"drug":{"id":7601,"name":"Emtricitabine","url":"cure-api2.ncats.io/v1/drugs/7601","rxNorm_id":null,"notes":null},"use_drug":[{"id":7316,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11007},{"id":7317,"answer":"In a novel combination with another drug","answer_other":"","regimen":11007}],"created":"2020-09-13T22:57:43.466621Z","updated":"2020-09-13T23:13:38.893974Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":5890},{"id":11008,"duration":{"id":5066,"approximate_duration":"on-going","dates_unknown":true},"drug":{"id":7166,"name":"Darunavir-Cobicistat","url":"cure-api2.ncats.io/v1/drugs/7166","rxNorm_id":null,"notes":null},"use_drug":[{"id":7318,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11008},{"id":7319,"answer":"In a novel combination with another drug","answer_other":"","regimen":11008}],"created":"2020-09-13T22:57:43.472864Z","updated":"2020-09-13T23:13:38.899887Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":5890},{"id":11009,"duration":{"id":5069,"approximate_duration":"4 days","dates_unknown":true},"drug":{"id":8467,"name":"Interferon Beta-1B","url":"cure-api2.ncats.io/v1/drugs/8467","rxNorm_id":null,"notes":null},"use_drug":[{"id":7320,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11009},{"id":7321,"answer":"In a novel combination with another drug","answer_other":"","regimen":11009}],"created":"2020-09-13T22:57:43.479037Z","updated":"2020-09-13T23:13:38.945191Z","dose":"250 μg (8 million units)","frequency":"Every 48 hours","route":"","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":5890},{"id":11010,"duration":{"id":5068,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7066,"name":"Corticosteroids","url":"cure-api2.ncats.io/v1/drugs/7066","rxNorm_id":null,"notes":null},"use_drug":[{"id":7322,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11010},{"id":7323,"answer":"In a novel combination with another drug","answer_other":"","regimen":11010}],"created":"2020-09-13T22:57:43.485073Z","updated":"2020-09-13T23:13:38.912200Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":5890},{"id":11011,"duration":{"id":5070,"approximate_duration":"5 days","dates_unknown":true},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":7324,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11011},{"id":7325,"answer":"In a novel combination with another drug","answer_other":"","regimen":11011}],"created":"2020-09-13T23:13:38.940553Z","updated":"2020-09-13T23:13:38.946132Z","dose":"400 mg twice a day with a loading dose on the first day and then 200 mg twice a day for 4 days","frequency":"BD","route":"","severity":null,"severity_detail":null,"comments":null,"report":5890}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":7705,"answer":"Clinical assessment","answer_other":"","report":5890}],"how_diagnosis":[{"id":13105,"answer":"Clinical assessment","answer_other":"","report":5890},{"id":13106,"answer":"Imaging","answer_other":"","report":5890},{"id":13107,"answer":"PCR","answer_other":"","report":5890}],"author_username":"Reema Charles","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Medical Doctor","author_affiliation":"None","author_country":"","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":3821,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":5890}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"},{"id":550,"name":"Respiratory Tract Infections"}],"races":[{"id":193,"answer":"White","answer_other":""}],"created":"2020-09-13T22:45:49.507533Z","updated":"2020-09-13T23:13:38.879563Z","title":"COVID-19 in patients with HIV: clinical case series. Case 5","status":"Approved","anonymous":false,"published":true,"pubmed_id":32304642,"doi":"10.1016/S2352-3018(20)30111-9","article_url":"https://pubmed.ncbi.nlm.nih.gov/32304642/","pub_year":2020,"published_authors":"Blanco JL\r\nAmbrosioni J\r\nGarcia F\r\nMartínez E\r\nSoriano A\r\nMallolas J\r\nMiro JM\r\nCOVID-19 in HIV Investigators.","article_author_email":"Author email could not be found.","journal":"The lancet. HIV","abstract":"On March 9, 2020, 2 weeks into the COVID-19 outbreak in Spain, 543 consecutive patients with SARS-CoV-2 infection had been admitted to hospital at Hospital Clínic Barcelona, Barcelona, Spain. We admitted 62 (12%) into intensive care units and we discharged 208 (38%) with supervised outpatient care. Of all patients, five (0·92%; 95% 0·39–2·14) were HIV positive, of whom three were male and two were transgender, and four identified as men who have sex with men (MSM). Two patients had comorbid conditions.","article_type":"Original","study_type":"Case Report","number_of_patients":5,"article_patient_number":"5","full_text_available":true,"outcome":"Patient was cured/recovered","surgery":"No","age":"31-40 years","sex":"Other","ethnicity":"Hispanic/Latino","country_contracted":"Spain","country_treated":"Spain","began_treatment_year":"2020","hiv":true,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Respiratory tract infection","severity":null,"prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"","follow_up_period":null,"relapse":"Unknown","reminder":false,"when_reminder":"1 week","additional_info":"Transgender\r\nMSM, sexual worker\r\nNo ART: current diagnosis is late presenter - diagnosed in 2020\r\nSpO2 <90%\r\nRight basal pneumonia with pleural effusion\r\nNon-invasive ventilation\r\nConcomitant Pneumocystis jiroveci and bacterial pneumonia treatment, Azithromycin (for 5 days), ceftaroline fosamil (for 7 days), co-trimoxazole (for 21 days, followed by secondary prophylaxis)","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[7066,7166,7601,8342,8467,11227]},{"id":6319,"regimens":[{"id":12203,"duration":{"id":6201,"approximate_duration":"16 Days","dates_unknown":true},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":9604,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12203},{"id":9605,"answer":"In a novel combination with another drug","answer_other":"","regimen":12203}],"created":"2020-10-26T18:44:46.299647Z","updated":"2020-10-26T18:58:52.151480Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"Under mechanical ventilation","comments":null,"report":6319},{"id":12204,"duration":{"id":6202,"approximate_duration":"16 Days","dates_unknown":true},"drug":{"id":8783,"name":"Lopinavir-Ritonavir","url":"cure-api2.ncats.io/v1/drugs/8783","rxNorm_id":null,"notes":null},"use_drug":[{"id":9606,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12204},{"id":9607,"answer":"In a novel combination with another drug","answer_other":"","regimen":12204}],"created":"2020-10-26T18:44:46.307696Z","updated":"2020-10-26T18:58:52.158080Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"Under mechanical ventilation","comments":null,"report":6319},{"id":12205,"duration":{"id":6203,"approximate_duration":"9 Days","dates_unknown":true},"drug":{"id":7066,"name":"Corticosteroids","url":"cure-api2.ncats.io/v1/drugs/7066","rxNorm_id":null,"notes":null},"use_drug":[{"id":9608,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12205},{"id":9609,"answer":"In a novel combination with another drug","answer_other":"","regimen":12205}],"created":"2020-10-26T18:44:46.314274Z","updated":"2020-10-26T18:58:52.163794Z","dose":"1mg/kg","frequency":"","route":"","severity":"Inpatient","severity_detail":"Under mechanical ventilation","comments":null,"report":6319},{"id":12206,"duration":{"id":6204,"approximate_duration":null,"dates_unknown":false},"drug":{"id":10776,"name":"Tocilizumab","url":"cure-api2.ncats.io/v1/drugs/10776","rxNorm_id":null,"notes":null},"use_drug":[{"id":9610,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12206},{"id":9611,"answer":"In a novel combination with another drug","answer_other":"","regimen":12206}],"created":"2020-10-26T18:44:46.320850Z","updated":"2020-10-26T18:58:52.169513Z","dose":"600mg","frequency":"2 Doses","route":"","severity":"Inpatient","severity_detail":"Under mechanical ventilation","comments":null,"report":6319}],"site_of_infection":[],"specific_site":[],"how_outcome":[],"how_diagnosis":[{"id":14158,"answer":"Clinical assessment","answer_other":"","report":6319},{"id":14159,"answer":"Imaging","answer_other":"","report":6319},{"id":14160,"answer":"PCR","answer_other":"","report":6319}],"author_username":"Paige Evans","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Nurse","author_affiliation":"None","author_country":"","outcome_computed":"Deteriorated","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4391,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6319},{"id":4392,"answer":"Co-Infection or Complex Co-morbidities","answer_other":"","report":6319}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"}],"races":[{"id":451,"answer":"Other","answer_other":""}],"created":"2020-10-26T18:43:04.659049Z","updated":"2020-10-26T18:58:52.143732Z","title":"Poor outcome in patients with acute leukemia on intensive chemotherapy and COVID-19. Case 1.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32499538,"doi":"10.1038/s41409-020-0961-y","article_url":"https://pubmed.ncbi.nlm.nih.gov/32499538/","pub_year":2020,"published_authors":"Núñez-Torrón C\r\nGarcía-Gutiérrez V\r\nTenorio-Núñez MC\r\nMoreno-Jiménez G\r\nLópez-Jiménez FJ\r\nHerrera-Puente P","article_author_email":"jvalentingg@gmail.com","journal":"Bone marrow transplantation","abstract":"We reviewed eight patients with AML that received a total of nine intensive AML chemotherapy\r\ncycles in a tertiary care hospital of which four were confirmed cases. To our knowledge, there are no current data evaluating the impact of concomitant COVID-19 in AML patients candidates to intensive therapy, and thus recommendations of expert panels are followed based on the available data in\r\nnonhematological population.","article_type":"Original","study_type":"Case Report","number_of_patients":4,"article_patient_number":"1","full_text_available":true,"outcome":"Patient died","surgery":"No","age":"","sex":"","ethnicity":null,"country_contracted":"Spain","country_treated":"Spain","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"Acute Myeloid Leukemia","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Pneumonia","severity":null,"prev_treatment":"","unusual":"Patient was undergoing chemotherapy for AML when COVID-19 was contracted.","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"At the time the treatment was completed","follow_up_period":null,"relapse":"No","reminder":false,"when_reminder":"1 week","additional_info":"Patient had undergone 9 intensive AML chemotherapy cycles in a tertiary care hospital where COVID-19 was acquired.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[7066,8342,8783,10776]},{"id":6320,"regimens":[{"id":12207,"duration":{"id":6205,"approximate_duration":"5 Days","dates_unknown":true},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":9612,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12207},{"id":9613,"answer":"In a novel combination with another drug","answer_other":"","regimen":12207}],"created":"2020-10-26T19:07:18.088262Z","updated":"2020-10-26T19:14:31.827435Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"Under mechanical ventilation","comments":null,"report":6320},{"id":12208,"duration":{"id":6206,"approximate_duration":"7 Days","dates_unknown":true},"drug":{"id":8783,"name":"Lopinavir-Ritonavir","url":"cure-api2.ncats.io/v1/drugs/8783","rxNorm_id":null,"notes":null},"use_drug":[{"id":9614,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12208},{"id":9615,"answer":"In a novel combination with another drug","answer_other":"","regimen":12208}],"created":"2020-10-26T19:07:18.096169Z","updated":"2020-10-26T19:14:31.834123Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"Under mechanical ventilation","comments":null,"report":6320},{"id":12209,"duration":{"id":6207,"approximate_duration":"3 Days","dates_unknown":true},"drug":{"id":7066,"name":"Corticosteroids","url":"cure-api2.ncats.io/v1/drugs/7066","rxNorm_id":null,"notes":null},"use_drug":[{"id":9616,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12209},{"id":9617,"answer":"In a novel combination with another drug","answer_other":"","regimen":12209}],"created":"2020-10-26T19:07:18.102492Z","updated":"2020-10-26T19:14:31.839943Z","dose":"250mg","frequency":"","route":"","severity":"Inpatient","severity_detail":"Under mechanical ventilation","comments":null,"report":6320}],"site_of_infection":[],"specific_site":[],"how_outcome":[],"how_diagnosis":[{"id":14161,"answer":"Clinical assessment","answer_other":"","report":6320},{"id":14162,"answer":"Imaging","answer_other":"","report":6320},{"id":14163,"answer":"PCR","answer_other":"","report":6320}],"author_username":"Paige Evans","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Nurse","author_affiliation":"None","author_country":"","outcome_computed":"Deteriorated","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4393,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6320},{"id":4394,"answer":"Co-Infection or Complex Co-morbidities","answer_other":"","report":6320}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"}],"races":[],"created":"2020-10-26T19:01:26.862648Z","updated":"2020-10-26T19:14:31.819479Z","title":"Poor outcome in patients with acute leukemia on intensive chemotherapy and COVID-19. Case 2.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32499538,"doi":"10.1038/s41409-020-0961-y","article_url":"https://pubmed.ncbi.nlm.nih.gov/32499538/","pub_year":2020,"published_authors":"Núñez-Torrón C\r\nGarcía-Gutiérrez V\r\nTenorio-Núñez MC\r\nMoreno-Jiménez G\r\nLópez-Jiménez FJ\r\nHerrera-Puente P","article_author_email":"jvalentingg@gmail.com","journal":"Bone marrow transplantation","abstract":"We reviewed eight patients with AML that received a total of nine intensive AML chemotherapy cycles in a tertiary care hospital of which four were confirmed cases. To our knowledge, there are no current data evaluating the impact of concomitant COVID-19 in AML patients candidates to intensive therapy, and thus recommendations of expert panels are followed based on the available data in nonhematological population.","article_type":"Original","study_type":"Case Report","number_of_patients":4,"article_patient_number":"2","full_text_available":true,"outcome":"Patient died","surgery":"No","age":"","sex":"","ethnicity":null,"country_contracted":"Spain","country_treated":"Spain","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"Acute Myeloid Leukemia","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Pneumonia","severity":null,"prev_treatment":"","unusual":"Patient was undergoing chemotherapy for AML when COVID-19 was contracted.","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"At the time the treatment was completed","follow_up_period":null,"relapse":"No","reminder":false,"when_reminder":"1 week","additional_info":"Patient had undergone 9 intensive AML chemotherapy cycles in a tertiary care hospital where COVID-19 was acquired.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[7066,8342,8783]},{"id":6321,"regimens":[{"id":12210,"duration":{"id":6208,"approximate_duration":"5 Days","dates_unknown":true},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":9618,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12210},{"id":9619,"answer":"In a novel combination with another drug","answer_other":"","regimen":12210}],"created":"2020-10-26T19:27:18.519075Z","updated":"2020-10-26T19:39:35.263875Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"Under mechanical ventilation","comments":null,"report":6321},{"id":12211,"duration":{"id":6209,"approximate_duration":"4 Days","dates_unknown":true},"drug":{"id":6122,"name":"Azithromycin","url":"cure-api2.ncats.io/v1/drugs/6122","rxNorm_id":null,"notes":null},"use_drug":[{"id":9620,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12211},{"id":9621,"answer":"In a novel combination with another drug","answer_other":"","regimen":12211}],"created":"2020-10-26T19:27:49.024588Z","updated":"2020-10-26T19:39:35.270272Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"Under mechanical ventilation","comments":null,"report":6321},{"id":12212,"duration":{"id":6210,"approximate_duration":"6 Days","dates_unknown":true},"drug":{"id":7066,"name":"Corticosteroids","url":"cure-api2.ncats.io/v1/drugs/7066","rxNorm_id":null,"notes":null},"use_drug":[{"id":9622,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12212},{"id":9623,"answer":"In a novel combination with another drug","answer_other":"","regimen":12212}],"created":"2020-10-26T19:27:49.031507Z","updated":"2020-10-26T19:39:35.276310Z","dose":"1mg/kg","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"Under mechanical ventilation","comments":null,"report":6321},{"id":12213,"duration":{"id":6211,"approximate_duration":null,"dates_unknown":false},"drug":{"id":10776,"name":"Tocilizumab","url":"cure-api2.ncats.io/v1/drugs/10776","rxNorm_id":null,"notes":null},"use_drug":[{"id":9624,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12213},{"id":9625,"answer":"In a novel combination with another drug","answer_other":"","regimen":12213}],"created":"2020-10-26T19:27:49.037842Z","updated":"2020-10-26T19:39:35.281843Z","dose":"600mg first dose, 400mg second dose","frequency":"2 Doses","route":"","severity":"ICU/Critical Care","severity_detail":"Under mechanical ventilation","comments":null,"report":6321}],"site_of_infection":[],"specific_site":[],"how_outcome":[],"how_diagnosis":[{"id":14164,"answer":"Clinical assessment","answer_other":"","report":6321},{"id":14165,"answer":"Imaging","answer_other":"","report":6321},{"id":14166,"answer":"PCR","answer_other":"","report":6321}],"author_username":"Paige Evans","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Nurse","author_affiliation":"None","author_country":"","outcome_computed":"Deteriorated","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4395,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6321},{"id":4396,"answer":"Co-Infection or Complex Co-morbidities","answer_other":"","report":6321}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"}],"races":[],"created":"2020-10-26T19:25:23.886918Z","updated":"2020-10-26T19:39:35.256299Z","title":"Poor outcome in patients with acute leukemia on intensive chemotherapy and COVID-19. Case 3.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32499538,"doi":"10.1038/s41409-020-0961-y","article_url":"https://pubmed.ncbi.nlm.nih.gov/32499538/","pub_year":2020,"published_authors":"Núñez-Torrón C\r\nGarcía-Gutiérrez V\r\nTenorio-Núñez MC\r\nMoreno-Jiménez G\r\nLópez-Jiménez FJ\r\nHerrera-Puente P","article_author_email":"jvalentingg@gmail.com","journal":"Bone marrow transplantation","abstract":"We reviewed eight patients with AML that received a total of nine intensive AML chemotherapy cycles in a tertiary care hospital of which four were confirmed cases. To our knowledge, there are no current data evaluating the impact of concomitant COVID-19 in AML patients candidates to intensive therapy, and thus recommendations of expert panels are followed based on the available data in nonhematological population.","article_type":"Original","study_type":"Case Report","number_of_patients":4,"article_patient_number":"3","full_text_available":true,"outcome":"Patient died","surgery":"No","age":"","sex":"","ethnicity":null,"country_contracted":"Spain","country_treated":"Spain","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"Acute Myeloid Leukemia","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Pneumonia","severity":null,"prev_treatment":"","unusual":"Patient was undergoing chemotherapy for AML when COVID-19 was contracted.","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"At the time the treatment was completed","follow_up_period":null,"relapse":"No","reminder":false,"when_reminder":"1 week","additional_info":"Patient had undergone 9 intensive AML chemotherapy cycles in a tertiary care hospital where COVID-19 was acquired.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[6122,7066,8342,10776]},{"id":6585,"regimens":[{"id":13067,"duration":{"id":6961,"approximate_duration":null,"dates_unknown":false},"drug":{"id":6122,"name":"Azithromycin","url":"cure-api2.ncats.io/v1/drugs/6122","rxNorm_id":null,"notes":null},"use_drug":[{"id":11290,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13067},{"id":11291,"answer":"In a novel combination with another drug","answer_other":"","regimen":13067}],"created":"2020-11-27T18:32:34.550914Z","updated":"2020-11-30T19:41:21.089620Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6585},{"id":13068,"duration":{"id":6962,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8783,"name":"Lopinavir-Ritonavir","url":"cure-api2.ncats.io/v1/drugs/8783","rxNorm_id":null,"notes":null},"use_drug":[{"id":11292,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13068},{"id":11293,"answer":"In a novel combination with another drug","answer_other":"","regimen":13068}],"created":"2020-11-27T18:32:34.558837Z","updated":"2020-11-30T19:41:21.095962Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6585},{"id":13069,"duration":{"id":6963,"approximate_duration":null,"dates_unknown":false},"drug":{"id":11396,"name":"Darunavir-Ritonavir","url":"cure-api2.ncats.io/v1/drugs/11396","rxNorm_id":null,"notes":null},"use_drug":[{"id":11294,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13069},{"id":11295,"answer":"In a novel combination with another drug","answer_other":"","regimen":13069}],"created":"2020-11-27T18:32:34.565678Z","updated":"2020-11-30T19:41:21.101509Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6585},{"id":13070,"duration":{"id":6964,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7066,"name":"Corticosteroids","url":"cure-api2.ncats.io/v1/drugs/7066","rxNorm_id":null,"notes":null},"use_drug":[{"id":11303,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13070},{"id":11304,"answer":"In a novel combination with another drug","answer_other":"","regimen":13070}],"created":"2020-11-27T18:32:34.572208Z","updated":"2020-11-30T19:41:21.107963Z","dose":"","frequency":"","route":"IV","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6585},{"id":13071,"duration":{"id":6965,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":11305,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13071},{"id":11306,"answer":"In a novel combination with another drug","answer_other":"","regimen":13071}],"created":"2020-11-27T18:32:34.578742Z","updated":"2020-11-30T19:41:21.113643Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6585},{"id":13072,"duration":{"id":6966,"approximate_duration":null,"dates_unknown":false},"drug":{"id":10776,"name":"Tocilizumab","url":"cure-api2.ncats.io/v1/drugs/10776","rxNorm_id":null,"notes":null},"use_drug":[{"id":11307,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13072},{"id":11308,"answer":"In a novel combination with another drug","answer_other":"","regimen":13072}],"created":"2020-11-27T18:32:34.585764Z","updated":"2020-11-30T19:41:21.119291Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6585},{"id":13073,"duration":{"id":6967,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7629,"name":"Enoxaparin","url":"cure-api2.ncats.io/v1/drugs/7629","rxNorm_id":null,"notes":null},"use_drug":[{"id":11309,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13073},{"id":11310,"answer":"In a novel combination with another drug","answer_other":"","regimen":13073}],"created":"2020-11-27T18:32:34.592795Z","updated":"2020-11-30T19:41:21.125039Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6585}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8651,"answer":"Clinical assessment","answer_other":"","report":6585}],"how_diagnosis":[{"id":14843,"answer":"Clinical assessment","answer_other":"","report":6585},{"id":14844,"answer":"Imaging","answer_other":"","report":6585}],"author_username":"Cure Admin","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Other Healthcare Professional","author_affiliation":"FDA/NCATS","author_country":"United States","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4758,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6585}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"},{"id":550,"name":"Respiratory Tract Infections"}],"races":[{"id":520,"answer":"White","answer_other":""}],"created":"2020-11-27T18:30:16.718399Z","updated":"2020-11-30T19:41:21.081197Z","title":"Acute myopathic quadriplegia in patients with COVID-19 in the intensive care unit. Case 3","status":"Approved","anonymous":false,"published":true,"pubmed_id":32601119,"doi":"10.1212/WNL.0000000000010280","article_url":"https://pubmed.ncbi.nlm.nih.gov/32601119/","pub_year":2020,"published_authors":"Madia F\r\nMerico B\r\nPrimiano G\r\nCutuli SL\r\nDe Pascale G\r\nServidei S","article_author_email":"Author email could not be found.","journal":"Neurology","abstract":"It is well known that the spectrum of SARS-CoV-2 infection ranges from asymptomatic or\r\nmildly symptomatic patients to rapidly progressive, acute respiratory distress syndrome\r\n(ARDS) and death. Although various reports indicated the presence of myalgia in 44%–70%\r\nand increased creatine kinase (CK) in about 33% of hospitalized patients,1 or <skeletal muscle\r\ninjury> (increased CK and myalgia) in 23%,2 the characterization of neuromuscular involvement is still unsatisfactory, and no electrophysiologic studies have been performed. Very\r\nrecently, patients who developed the Guillain-Barr´e syndrome (GBS) in the course of coronavirus disease 2019 (COVID-19) have been described.3 In the past literature, there were a few\r\nreports of neuromuscular involvement in association with other beta-coronavirus, including\r\ncritical illness myopathy (CIM) or polyneuropathy.1,4 Moreover, myopathic changes, as fiber\r\natrophy or necrosis, have been reported in postmortem muscle samples of 8 patients who died\r\nof SARS (severe acute respiratory syndrome) due to SARS-CoV infection.4","article_type":"Original","study_type":"Case Report","number_of_patients":6,"article_patient_number":"3","full_text_available":true,"outcome":"Patient improved","surgery":"No","age":"51-60 years","sex":"Male","ethnicity":"Hispanic/Latino","country_contracted":"Italy","country_treated":"Italy","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"None","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Pneumonia, acute flaccid quadriplegia","severity":null,"prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"","follow_up_period":null,"relapse":"Unknown","reminder":false,"when_reminder":"1 week","additional_info":"Mechanical ventilation +\r\nPneumonia with characteristic bilateral patchy ground-glass opacities and interstitial changes and various superimposed infections or sepsis\r\nTherapies used:  Azithromycin, ceftriaxone, levofloxacin, linezolid, vancomycin, amikacin, meropenem, lopinavir/ ritonavir, darunavir/ ritonavir, endovenous corticosteroids, hydroxychloroquine, tocilizumab, and enoxaparin","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[6122,7066,11396,7629,8342,8783,10776]},{"id":6586,"regimens":[{"id":13075,"duration":{"id":6968,"approximate_duration":null,"dates_unknown":false},"drug":{"id":6122,"name":"Azithromycin","url":"cure-api2.ncats.io/v1/drugs/6122","rxNorm_id":null,"notes":null},"use_drug":[{"id":11316,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13075},{"id":11317,"answer":"In a novel combination with another drug","answer_other":"","regimen":13075}],"created":"2020-11-27T18:44:56.048069Z","updated":"2020-11-30T19:41:54.398883Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6586},{"id":13076,"duration":{"id":6969,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7518,"name":"Doxycycline","url":"cure-api2.ncats.io/v1/drugs/7518","rxNorm_id":null,"notes":null},"use_drug":[{"id":11318,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13076},{"id":11319,"answer":"In a novel combination with another drug","answer_other":"","regimen":13076}],"created":"2020-11-27T18:44:56.055782Z","updated":"2020-11-30T19:41:54.405287Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6586},{"id":13077,"duration":{"id":6970,"approximate_duration":null,"dates_unknown":false},"drug":{"id":11396,"name":"Darunavir-Ritonavir","url":"cure-api2.ncats.io/v1/drugs/11396","rxNorm_id":null,"notes":null},"use_drug":[{"id":11320,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13077},{"id":11321,"answer":"In a novel combination with another drug","answer_other":"","regimen":13077}],"created":"2020-11-27T18:44:56.063003Z","updated":"2020-11-30T19:41:54.410814Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6586},{"id":13078,"duration":{"id":6971,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7066,"name":"Corticosteroids","url":"cure-api2.ncats.io/v1/drugs/7066","rxNorm_id":null,"notes":null},"use_drug":[{"id":11322,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13078},{"id":11323,"answer":"In a novel combination with another drug","answer_other":"","regimen":13078}],"created":"2020-11-27T18:44:56.069181Z","updated":"2020-11-30T19:41:54.416159Z","dose":"","frequency":"","route":"IV","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6586},{"id":13079,"duration":{"id":6972,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":11324,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13079},{"id":11325,"answer":"In a novel combination with another drug","answer_other":"","regimen":13079}],"created":"2020-11-27T18:44:56.075451Z","updated":"2020-11-30T19:41:54.421499Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6586},{"id":13080,"duration":{"id":6973,"approximate_duration":null,"dates_unknown":false},"drug":{"id":11304,"name":"Sarilumab","url":"cure-api2.ncats.io/v1/drugs/11304","rxNorm_id":null,"notes":null},"use_drug":[{"id":11326,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13080},{"id":11327,"answer":"In a novel combination with another drug","answer_other":"","regimen":13080}],"created":"2020-11-27T18:44:56.081733Z","updated":"2020-11-30T19:41:54.427335Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6586},{"id":13081,"duration":{"id":6974,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7629,"name":"Enoxaparin","url":"cure-api2.ncats.io/v1/drugs/7629","rxNorm_id":null,"notes":null},"use_drug":[{"id":11328,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13081},{"id":11329,"answer":"In a novel combination with another drug","answer_other":"","regimen":13081}],"created":"2020-11-27T18:44:56.087903Z","updated":"2020-11-30T19:41:54.433144Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6586}],"site_of_infection":[],"specific_site":[],"how_outcome":[],"how_diagnosis":[{"id":14845,"answer":"Clinical assessment","answer_other":"","report":6586},{"id":14846,"answer":"Imaging","answer_other":"","report":6586}],"author_username":"Cure Admin","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Other Healthcare Professional","author_affiliation":"FDA/NCATS","author_country":"United States","outcome_computed":"Deteriorated","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4759,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6586}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"},{"id":550,"name":"Respiratory Tract Infections"}],"races":[{"id":521,"answer":"White","answer_other":""}],"created":"2020-11-27T18:42:08.186728Z","updated":"2020-11-30T19:41:54.390950Z","title":"Acute myopathic quadriplegia in patients with COVID-19 in the intensive care unit. Case 4","status":"Approved","anonymous":false,"published":true,"pubmed_id":32601119,"doi":"10.1212/WNL.0000000000010280","article_url":"https://pubmed.ncbi.nlm.nih.gov/32601119/","pub_year":2020,"published_authors":"Madia F\r\nMerico B\r\nPrimiano G\r\nCutuli SL\r\nDe Pascale G\r\nServidei S","article_author_email":"Author email could not be found.","journal":"Neurology","abstract":"It is well known that the spectrum of SARS-CoV-2 infection ranges from asymptomatic or\r\nmildly symptomatic patients to rapidly progressive, acute respiratory distress syndrome\r\n(ARDS) and death. Although various reports indicated the presence of myalgia in 44%–70%\r\nand increased creatine kinase (CK) in about 33% of hospitalized patients,1 or <skeletal muscle\r\ninjury> (increased CK and myalgia) in 23%,2 the characterization of neuromuscular involvement is still unsatisfactory, and no electrophysiologic studies have been performed. Very\r\nrecently, patients who developed the Guillain-Barr´e syndrome (GBS) in the course of coronavirus disease 2019 (COVID-19) have been described.3 In the past literature, there were a few\r\nreports of neuromuscular involvement in association with other beta-coronavirus, including\r\ncritical illness myopathy (CIM) or polyneuropathy.1,4 Moreover, myopathic changes, as fiber\r\natrophy or necrosis, have been reported in postmortem muscle samples of 8 patients who died\r\nof SARS (severe acute respiratory syndrome) due to SARS-CoV infection.4","article_type":"Original","study_type":"Case Report","number_of_patients":6,"article_patient_number":"4","full_text_available":true,"outcome":"Patient died","surgery":"No","age":"71-80 years","sex":"Male","ethnicity":"Hispanic/Latino","country_contracted":"Italy","country_treated":"Italy","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":true,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Pneumonia, acute flaccid quadriplegia","severity":null,"prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"","follow_up_period":null,"relapse":"","reminder":false,"when_reminder":"1 week","additional_info":"Mechanical ventilation +\r\npneumonia with characteristic bilateral patchy ground-glass opacities and interstitial changes and various superimposed infections or sepsis.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[6122,7066,11396,7518,7629,8342,11304]},{"id":6587,"regimens":[{"id":13082,"duration":{"id":6975,"approximate_duration":null,"dates_unknown":false},"drug":{"id":11396,"name":"Darunavir-Ritonavir","url":"cure-api2.ncats.io/v1/drugs/11396","rxNorm_id":null,"notes":null},"use_drug":[{"id":11331,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13082},{"id":11332,"answer":"In a novel combination with another drug","answer_other":"","regimen":13082}],"created":"2020-11-27T18:58:29.277123Z","updated":"2020-11-30T19:42:26.691024Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6587},{"id":13083,"duration":{"id":6976,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":11333,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13083},{"id":11334,"answer":"In a novel combination with another drug","answer_other":"","regimen":13083}],"created":"2020-11-27T18:58:29.285422Z","updated":"2020-11-30T19:42:26.697289Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6587},{"id":13084,"duration":{"id":6977,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7066,"name":"Corticosteroids","url":"cure-api2.ncats.io/v1/drugs/7066","rxNorm_id":null,"notes":null},"use_drug":[{"id":11335,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13084},{"id":11336,"answer":"In a novel combination with another drug","answer_other":"","regimen":13084}],"created":"2020-11-27T18:58:29.292045Z","updated":"2020-11-30T19:42:26.702936Z","dose":"","frequency":"","route":"IV","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6587},{"id":13085,"duration":{"id":6978,"approximate_duration":null,"dates_unknown":false},"drug":{"id":10776,"name":"Tocilizumab","url":"cure-api2.ncats.io/v1/drugs/10776","rxNorm_id":null,"notes":null},"use_drug":[{"id":11337,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13085},{"id":11338,"answer":"In a novel combination with another drug","answer_other":"","regimen":13085}],"created":"2020-11-27T18:58:29.298290Z","updated":"2020-11-30T19:42:26.709100Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6587},{"id":13086,"duration":{"id":6979,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7629,"name":"Enoxaparin","url":"cure-api2.ncats.io/v1/drugs/7629","rxNorm_id":null,"notes":null},"use_drug":[{"id":11339,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13086},{"id":11340,"answer":"In a novel combination with another drug","answer_other":"","regimen":13086}],"created":"2020-11-27T18:58:29.304592Z","updated":"2020-11-30T19:42:26.714858Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6587}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8652,"answer":"Clinical assessment","answer_other":"","report":6587}],"how_diagnosis":[{"id":14848,"answer":"Clinical assessment","answer_other":"","report":6587},{"id":14849,"answer":"Imaging","answer_other":"","report":6587}],"author_username":"Cure Admin","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Other Healthcare Professional","author_affiliation":"FDA/NCATS","author_country":"United States","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4760,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6587}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"},{"id":550,"name":"Respiratory Tract Infections"}],"races":[{"id":522,"answer":"White","answer_other":""}],"created":"2020-11-27T18:56:44.952103Z","updated":"2020-11-30T19:42:26.683381Z","title":"Acute myopathic quadriplegia in patients with COVID-19 in the intensive care unit. Case 5","status":"Approved","anonymous":false,"published":true,"pubmed_id":32601119,"doi":"10.1212/WNL.0000000000010280","article_url":"https://pubmed.ncbi.nlm.nih.gov/32601119/","pub_year":2020,"published_authors":"Madia F\r\nMerico B\r\nPrimiano G\r\nCutuli SL\r\nDe Pascale G\r\nServidei S","article_author_email":"Author email could not be found.","journal":"Neurology","abstract":"It is well known that the spectrum of SARS-CoV-2 infection ranges from asymptomatic or\r\nmildly symptomatic patients to rapidly progressive, acute respiratory distress syndrome\r\n(ARDS) and death. Although various reports indicated the presence of myalgia in 44%–70%\r\nand increased creatine kinase (CK) in about 33% of hospitalized patients,1 or <skeletal muscle\r\ninjury> (increased CK and myalgia) in 23%,2 the characterization of neuromuscular involvement is still unsatisfactory, and no electrophysiologic studies have been performed. Very\r\nrecently, patients who developed the Guillain-Barr´e syndrome (GBS) in the course of coronavirus disease 2019 (COVID-19) have been described.3 In the past literature, there were a few\r\nreports of neuromuscular involvement in association with other beta-coronavirus, including\r\ncritical illness myopathy (CIM) or polyneuropathy.1,4 Moreover, myopathic changes, as fiber\r\natrophy or necrosis, have been reported in postmortem muscle samples of 8 patients who died\r\nof SARS (severe acute respiratory syndrome) due to SARS-CoV infection.4","article_type":"Original","study_type":"Case Report","number_of_patients":6,"article_patient_number":"5","full_text_available":true,"outcome":"Patient improved","surgery":"No","age":"51-60 years","sex":"Male","ethnicity":"Hispanic/Latino","country_contracted":"Italy","country_treated":"Italy","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"None","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Pneumonia, acute flaccid quadriplegia","severity":null,"prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"","follow_up_period":null,"relapse":"Unknown","reminder":false,"when_reminder":"1 week","additional_info":"Mechanical ventilation +\r\npneumonia with characteristic bilateral patchy ground-glass opacities and interstitial changes and various superimposed infections or sepsis.\r\nTherapies used:  Linezolid, imipenem, amoxicillin, darunavir/ ritonavir, endovenous corticosteroids, hydroxychloroquine, tocilizumab, and enoxaparin","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[7066,11396,7629,8342,10776]}]